ClinicalTrials.Veeva

Menu

Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection (Anosmie-COVID)

C

Centre Hospitalier Universitaire de Nīmes

Status

Completed

Conditions

COVID-19

Treatments

Other: olfactory and gustatory tests

Study type

Observational

Funder types

Other

Identifiers

NCT04354857
IRB: 20.04.09

Details and patient eligibility

About

Loss of sense of smell and taste has been anecdotally reported during the covid-19 epidemic. The study investigators wanted to describe the prevalence of olfactory and gustatory dysfunction and assess the factors associated with positive SARS-CoV-2 infection.

Enrollment

454 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients presenting with COVID-19 related symptoms including: fever, persistent cough, fatigue, shortness of breath, diarrhoea, abdominal pain, chest pain, sore throat, loss of smell or taste
  • Subjects in prolonged contact with COVID-19 infected patients.

Exclusion criteria

  • Patients directly admitted to the intensive care unit were excluded
  • Patients opposing use of their health data

Trial design

454 participants in 2 patient groups

RT-PCR SARS-CoV-2 positive
Treatment:
Other: olfactory and gustatory tests
RT-PCR SARS-CoV-2 negative
Treatment:
Other: olfactory and gustatory tests

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems